ExploreWatchlistsPricing
  1. JP-listed companies
  2. KANEKA CORPORATION
  3. Financials
  4. Accounts receivable, net

KANEKA CORPORATION (4118)

Market cap
¥339.7B
P/E ratio
10.1x
Kaneka develops advanced materials, medical devices, solar technology, and nutrition products across four business units serving infrastructure, housing, healthcare, and food industries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Mar 31, 2025176,793-5.14%
Mar 31, 2024186,371+9.53%
Mar 31, 2023170,154+3.67%
Mar 31, 2022164,128+21.02%
Mar 31, 2021135,618+1.12%
Mar 31, 2020134,110-9.38%
Mar 31, 2019147,993+4.08%
Mar 31, 2018142,194+13.32%
Mar 31, 2017125,482+3.12%
Mar 31, 2016121,682-0.33%
Mar 31, 2015122,083

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat